Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	28.58	31.17	73.98	50.71	71.72	9.77
Short-Term Investments	37.23	73.94	22.52	106.51	151.16	54.38
Cash & Short-Term Investments	65.81	105.11	96.5	157.22	222.88	64.16
Cash Growth	-57.04%	8.92%	-38.62%	-29.46%	247.39%	-37.87%
Accounts Receivable	37.1	12.1	-	-	-	8.28
Other Receivables	-	1.32	2.25	31.54	38.44	3.69
Receivables	37.1	13.43	2.25	31.54	38.44	11.98
Inventory	16.1	10.38	-	-	-	3.57
Prepaid Expenses	6.31	4.37	1.52	3.18	1.02	2.12
Other Current Assets	1.95	0.91	0.57	0.55	1.12	0.56
Total Current Assets	127.26	134.2	100.84	192.49	263.45	82.38
Property, Plant & Equipment	13.76	13.08	13.24	11.49	8.16	10.58
Goodwill	16.84	16.84	16.84	16.84	16.84	18.49
Other Intangible Assets	-	-	-	-	-	0.81
Long-Term Deferred Tax Assets	-	-	-	24.13	18.26	29.43
Other Long-Term Assets	0.4	0.58	1.87	2.33	4.93	9.74
Total Assets	158.25	164.7	132.79	247.27	311.64	151.44
Accounts Payable	7.92	11.43	7.89	7.68	2.93	6.1
Accrued Expenses	20.43	19.45	8.51	12.03	8.68	19.56
Current Portion of Long-Term Debt	1.88	0.73	37.67	-	-	5.55
Current Portion of Leases	0.73	0.93	0.96	0.9	0.47	0.65
Other Current Liabilities	11.83	4.31	0.77	0.39	3.03	4.13
Total Current Liabilities	42.78	36.86	55.79	21	15.11	35.98
Long-Term Debt	34.44	32.76	91.61	142.4	128.21	121.69
Long-Term Leases	1.22	1.69	0.78	1.71	1.84	2.32
Other Long-Term Liabilities	5.15	5.65	5.74	3.92	4.21	20.65
Total Liabilities	83.59	76.96	153.93	169.02	149.37	180.64
Common Stock	0.96	0.9	0.63	0.59	0.58	0.43
Additional Paid-In Capital	886.79	855.45	589.78	549.35	566.92	434.39
Retained Earnings	-789.29	-745.5	-585.22	-447.76	-384.19	-391.22
Treasury Stock	-	-	-	-	-	-50
Comprehensive Income & Other	-23.8	-23.17	-26.34	-23.94	-21.05	-22.81
Total Common Equity	74.66	87.69	-21.15	78.24	162.26	-29.2
Shareholders' Equity	74.66	87.74	-21.15	78.24	162.27	-29.2
Total Liabilities & Equity	158.25	164.7	132.79	247.27	311.64	151.44
Total Debt	38.25	36.11	131.02	145	130.52	130.2
Net Cash (Debt)	27.55	69	-34.52	12.22	92.36	-66.05
Net Cash Growth	-71.88%	-	-	-86.77%	-	-
Net Cash Per Share	0.29	0.86	-0.57	0.21	1.68	-1.77
Filing Date Shares Outstanding	96.36	90.58	64.48	59.03	58.47	46.4
Total Common Shares Outstanding	96.34	89.83	62.88	58.62	58.4	37.52
Working Capital	84.48	97.35	45.05	171.49	248.35	46.4
Book Value Per Share	0.78	0.98	-0.34	1.33	2.78	-0.78
Tangible Book Value	57.83	70.85	-37.99	61.4	145.43	-48.5
Tangible Book Value Per Share	0.60	0.79	-0.60	1.05	2.49	-1.29
Machinery	-	0.63	0.63	0.3	0.3	0.3

Source: S&P Capital IQ. Standard template. Financial Sources.